All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Adult Acute Erythroid Leukemia | NCIT_C9153 | [An acute erythroid leukemia occurring in adults.] |
| Adult Erythroleukemia | NCIT_C68694 | [An erythroleukemia occurring in adults.] |
| Adult Acute Promyelocytic Leukemia with t(15;17)(q22;q12); PML/RARA | NCIT_C68695 | [An acute promyelocytic leukemia with t(15;17)(q22;q12) occurring in adults.] |
| Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A | NCIT_C68696 | [An acute myeloid leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A occurring in adults.] |
| Adult Acute Myeloid Leukemia with Recurrent Genetic Abnormalities | NCIT_C68700 | [An acute myeloid leukemia with recurrent genetic abnormalities occurring in adults.] |
| Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A | NCIT_C82403 | [An acute myeloid leukemia associated with t(9;11)(p21.3;q23.3) and MLLT3-KMT2A fusion protein expression. Morphologically it usually has monocytic features. It may present at any age but it is more commonly seen in children. Patients may present with disseminated intravascular coagulation.] |
| Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 | NCIT_C68697 | [An acute myeloid leukemia with inv(16)(p13.1q22) occurring in adults.] |
| Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 | NCIT_C9018 | [Acute myeloid leukemia characterized by the presence of abnormal bone marrow eosinophils and the characteristic cytogenetic abnormality inv(16)(p13.1q22) which results in the expression of the fusion protein CBFB-MYH11.] |
| Randomization Weight | NCIT_C93642 | [The relative proportion of subjects to be randomized.] |
| Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | NCIT_C68698 | [An acute myeloid leukemia with t(16;16)(p13.1;q22) occurring in adults.] |
| Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | NCIT_C9019 | [Acute myeloid leukemia characterized by the presence of abnormal bone marrow eosinophils and the characteristic cytogenetic abnormality t(16;16)(p13.1;q22) which results in the expression of the fusion protein CBFB-MYH11.] |
| Drop Metastasis | NCIT_C54036 | |
| Pseudostratified Neuroepithelial Tumor Cells Present | NCIT_C54037 | |
| Pseudostratified Tumor Cells Present | NCIT_C54038 | |
| Registration Required Indicator | NCIT_C93646 | [Specifies whether registration to an event or activity is mandatory.] |
| Classic Medulloblastoma | NCIT_C54039 | [A medulloblastoma composed of malignant cells with hyperchromatic nucleus and scanty cytoplasm. Homer Wright rosettes may be present.] |
| Medulloblastoma | NCIT_C3222 | [A malignant, invasive embryonal neoplasm arising from the cerebellum or posterior fossa. It occurs predominantly in children and has the tendency to metastasize via the cerebrospinal fluid pathways. Signs and symptoms include truncal ataxia, disturbed gait, lethargy, headache, and vomiting. There are four histologic variants: classic medulloblastoma, large cell/anaplastic medulloblastoma, desmoplastic/nodular medulloblastoma, and medulloblastoma with extensive nodularity.] |
| Macrogol 3350-Based Iso-Osmotic Laxative | NCIT_C29080 | [An isotonic solution containing macrogol 3350 and electrolytes with laxative activity. Macrogol 3350-based oral osmotic laxative promotes the retention of water in the bowel, thereby increasing the water content of stool, which results in increased gastrointestinal motility and stool transit time and evacuation of colonic contents. Macrogol 3350 is also known as polyethylene glycol (PEG) 3350.] |
| Ratio | NCIT_C44256 | [Quotient of quantities of the same kind for different components within the same system.] |
| Guaifenesin | NCIT_C29081 | [A glyceryl guaiacolate with expectorant effects. Guaifenesin increases respiratory tract mucus secretions, acts as an irritant to gastric vagal receptors and recruits efferent parasympathetic reflexes that cause glandular exocytosis. This agent reduces the viscosity of mucus secretion by reducing adhesiveness and surface tension as well as increasing hydration of mucus. Guaifenesin promotes the efficiency of the mucociliary mechanism important in removing accumulated secretions from the upper and lower airway.] |